SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hansen (HNSN)
HNSN 3.9900.0%Jul 28 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
From: Arthur Radley12/21/2006 12:37:28 PM
   of 8
 
As for HNSN....this is my reason:

Andrea Natale, M.D., director for the Center for Atrial Fibrillation, director of the Electrophysiology Laboratories and head of the Section of Pacing and Electrophysiology, Cleveland Clinic Foundation, used the system during clinical evaluation on 23 patients at the Institute for Clinical and Experimental Medicine in Prague, Czech Republic, and the Klinikum Coburg in Germany. "In my experience, the stability of the catheter allowed us to perform diagnostic and therapeutic procedures more efficiently and effectively," said Dr. Natale. "Moreover, the incorporation of the new Sensei system and catheter did not add time to the procedures, nor did it require increased radiation time, as would normally be expected with new technology. As a result, I would expect this new system to someday become the medical standard for catheter guidance during percutaneous procedures."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext